[Effect of 2 amino acid inhibitors on adrenergic contraction].
D000596:Amino Acids / Q000037:antagonists & inhibitors*; D000818:Animals; D001013:Aorta, Thoracic / Q000187:drug effects*; D001593:Benzyl Compounds / Q000494:pharmacology; D002462:Cell Membrane / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004837:Epinephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D007202:Indicators and Reagents / Q000494:pharmacology; D007461:Iodoacetates / Q000494:pharmacology*; D007700:Kinetics; D008722:Methods; D009119:Muscle Contraction / Q000187:drug effects*; D009130:Muscle, Smooth / Q000187:drug effects; D010636:Phenols / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011817:Rabbits; D011955:Receptors, Drug; D014043:Tolazoline / Q000494:pharmacology; D014666:Vasomotor System / Q000187:drug effects
D000596:Amino Acids; D001593:Benzyl Compounds; D007202:Indicators and Reagents; D007461:Iodoacetates; D010636:Phenols; D011955:Receptors, Drug; D014043:Tolazoline; D004837:Epinephrine; D010646:Phentolamine
Action de deux inhibiteurs d'acides aminés sur la contraction adrénergique.